Bredesen protocol pdf

Dale E. Bredesen, M.D.

Dr. Bredesen graduated from Caltech and received his MD from Duke.  He served as Resident and Chief Resident in Neurology at UCSF, then postdoctoral fellow with Nobel laureate Prof. Stanley Prusiner.  He was the Founding President of the Buck Institute for Research on Aging.

The Bredesen Laboratory studied basic mechanisms underlying the neurodegenerative process, and the translation into effective therapeutics for Alzheimer’s disease, leading to the publication of over 220 research papers. He established the Alzheimer’s Drug Development Network with Dr. Varghese John, leading to the identification of new classes of therapeutics for Alzheimer’s disease.  His work led to the discovery of subtypes of Alzheimer’s disease, followed by the first description of reversal of symptoms in patients with MCI and Alzheimer’s disease, with a precision medicine protocol, and a recent successful proof-of-concept trial.  Dr. Bredesen is the author of two New York Times best sellers. He is currently a professor at UCLA.

About

Phil Bredesen grew up in rural Shortsville, N.Y, and earned a bachelor’s degree in physics from Harvard University. Before entering public service, Bredesen worked in the health care industry. He founded HealthAmerica Corp., a Nashville-based health care management company. He served as mayor of Nashville, Tenn., from 1991 to 1999.

Bredesen took office as Tennessee’s 48th governor in January 2003 and was reelected in November 2006, winning all 95 of the state’s counties. By Bredesen’s fourth year in office, Tennessee passed four balanced budgets, received improved rankings from bond rating agencies, and raised its Rainy Day Fund to a record high. Bredesen expanded the state’s pilot Pre-K initiative into a voluntary program for four-year-olds across the state and created the Governor’s Books from Birth Foundation, a statewide expansion of Dolly Parton’s Imagination Library to offer children free books monthly up to their fifth birthday in each of Tennessee’s counties. Bredesen launched CoverTN and CoverKids to provide health insurance for working Tennesseans and

Dale Bredesen, MD

Dale Bredesen, MD, is an internationally recognized neurologist with specialty expertise in the mechanisms of neurodegenerative diseases. He is the senior director of Precision Brain Health at Pacific Neuroscience Institute® and the Chief Scientific Officer at Apollo Health.

Guided by his philosophy and belief that Alzheimer’s disease it is not just preventable, but reversible, Dr. Bredesen’s innovative research has helped explain the physical mechanism behind the erosion of memory seen in Alzheimer’s disease. His decades of clinical study and neurological research have opened the door to new approaches of treatment leading to the ReCODE Protocol™. Also known as the Bredesen Protocol, this methodology has emerged as a viable attempt to prevent, arrest, and reverse symptoms of cognitive decline associated with conditions such as Alzheimer’s disease, dementias, and mild cognitive impairment.

Dr. Bredesen earned his medical degree from Duke University Medical Center and served as Chief Resident in Neurology at the University of C

Copyright ©airtory.pages.dev 2025